N Engl J Med · 2015

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

Larkin J, Chiarion-Sileni V, Gonzalez R, Grob JJ, Cowey CL, Lao CD, Schadendorf D, Dummer R, Smylie M, Rutkowski P, Ferrucci PF, Hill A, Wagstaff J, Carlino MS, Haanen JB, Maio M, Marquez-Rodas I, McArthur GA, Ascierto PA, Long GV, Callahan MK, Postow MA, Grossmann K, Sznol M, Dreno B, Bastholt L, Yang A, Rollin LM, Horak C, Hodi FS, Wolchok JD.

Show affiliations
  • Larkin JFrom the Department of Medical Oncology, Royal Marsden Hospital, London (J.L.), and South West Wales Cancer Institute, Singleton Hospital, Swansea (J.W.) - both in the United Kingdom; Melanoma Oncology Unit, Veneto Region Oncology Research Institute, Padua (V.C.-S.), Oncology of Melanoma Unit, European Institute of Oncology, Milan (P.F.F.), University Hospital of Siena, Siena (M.M.), and Istituto Nazionale Tumori Fondazione Pascale, Naples (P.A.A.) - all in Italy; Division of Medical Oncology, University of Colorado, Denver, Denver (R.G.); Aix-Marseille University, Hôpital de La Timone, Assitance Publique-Hôpitaux de Marseille, Marseille (J.J.G.), and Hôtel Dieu Place Alexis Ricordeau, Nantes (B.D.) - both in France; Baylor Charles A. Sammons Cancer Center, Dallas (C.L.C.); Departments of Internal Medicine and Dermatology, University of Michigan, Ann Arbor (C.D.L.); Department of Dermatology, University of Essen, Essen, Germany (D.S.); University of Zürich Hospital, Zurich, Switzerland (R.D.); Cross Cancer Institute, Edmonton, AB, Canada (M. Smylie); Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland (P.R.); Tasman Oncology Research, Southport Gold Coast, QLD (A.H.), and Westmead and Blacktown Hospitals (M.S.C.) and Melanoma Institute Australia (M.S.C., G.V.L.), University of Sydney, and the Mater Hospital (G.V.L.), Sydney, and Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, VIC (G.A.M.) - all in Australia; Division of Medical Oncology, the Netherlands Cancer Institute, Amsterdam (J.B.H.); Servicio de Oncología Médica, Hospital General Universitario Gregorio Marañón, Madrid (I.M.-R.); Ludwig Center, Memorial Sloan Kettering Cancer Center (M.K.C., M.A.P., J.D.W.) and Weill Cornell Medical College (M.K.C., M.A.P., J.D.W.) - both in New York; Huntsman Cancer Institute, University of Utah, Salt Lake City (K.G.); Yale Cancer Center, Smilow Cancer Hospital of the Yale-New Haven Hospital, Yale University Sc
23 read5 want to readRigor 2.6Novelty 2.7Impact 3.0Reprod. 3.3

Most-cited papers citing this

  • Mol Biomed · 2025 · cited by 5
  • Nat Cancer · 2026 · cited by 4
  • Nat Med · 2026 · cited by 3
  • Curr Pharm Des · 2026 · cited by 3
  • J Hematol Oncol · 2025 · cited by 3

Log in to like, log, and share thoughts on this paper.

Discussion

Share your thoughts above to start a thread. Constructive feedback only — reply to and like others’ posts.

0

Jonas Brown

Rigor 2/5Novelty 5/5Impact 1/5Reprod. 1/5

Replication is unclear to me.

0

Tariq Cohen

Rigor 2/5Novelty 3/5Impact 4/5Reprod. 4/5

Nice but incremental.

0

Eva Brown

Rigor 4/5Novelty 4/5Impact 1/5Reprod. 3/5

Great figures and clear story.

0

Tom Rossi

Rigor 3/5Novelty 2/5Impact 5/5Reprod. 5/5

Nice but incremental.

0

Ravi Sato

Rigor 1/5Novelty 1/5Impact 2/5Reprod. 4/5

Great figures and clear story.

0

Ines Brown

Rigor 4/5Novelty 2/5Impact 2/5Reprod. 2/5

Great figures and clear story.

0

Ken Park

Rigor 1/5Novelty 1/5Impact 5/5Reprod. 3/5

Great figures and clear story.

0

Sara Kim

Rigor 1/5Novelty 3/5Impact 4/5Reprod. 5/5

Nice but incremental.

0

Nadia Wang

Rigor 3/5Novelty 1/5Impact 2/5Reprod. 3/5

Great figures and clear story.

0

Alex Patel

Rigor 2/5Novelty 2/5Impact 3/5Reprod. 4/5

Important contribution to the field.

0

Sara Lee

Rigor 3/5Novelty 5/5Impact 2/5Reprod. 3/5

Important contribution to the field.